☆ 4.6 Article

Honokiol in glioblastoma recurrence: a case report

FRONTIERS IN NEUROLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Oncology

Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement

Stephen J. Bagley et al.

Summary: This article reviews the limited therapeutic advances for glioblastoma and the failure of recent clinical trials, and emphasizes the need for improvement in clinical trial conduct. Challenges related to clinical trial eligibility criteria and trial design in glioblastoma are identified, and data-driven analysis of current glioblastoma clinical trials is provided.

CLINICAL CANCER RESEARCH (2022)

添加到收藏夹

Review Medicine, Research & Experimental

Intracranial dissemination of glioblastoma multiforme: a case report and literature review

Keke Zhang et al.

Summary: Intracranial dissemination is rare in patients with GBM, and most patients do not survive long enough for it to become clinically evident. We report a case of a 39-year-old female GBM patient who underwent various treatments but eventually died due to dissemination. Heightened awareness and appropriate surgical strategies can minimize the risk of intracranial dissemination in GBM patients.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Recurrent Glioblastoma Treatment: State of the Art and Future Perspectives in the Precision Medicine Era

Augusto Leone et al.

Summary: The current treatment guidelines for recurrent glioblastoma are still uncertain, and further research and clinical trials are needed to provide better treatment strategies. For patients who fail initial treatment and show signs of disease progression, clinicians need to consider the patient's medical history and molecular characteristics to develop personalized treatment plans.

BIOMEDICINES (2022)

添加到收藏夹

Letter Biochemistry & Molecular Biology

Liposomal Honokiol induces ROS-mediated apoptosis via regulation of ERK/p38-MAPK signaling and autophagic inhibition in human medulloblastoma

Shenglan Li et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

添加到收藏夹

Article Oncology

Liposomal honokiol inhibits glioblastoma growth through regulating macrophage polarization

Shenglan Li et al.

Summary: Honokiol inhibits glioblastoma growth by upregulating M1 macrophages and limiting M2 phenotypic macrophages.

ANNALS OF TRANSLATIONAL MEDICINE (2021)

添加到收藏夹

Review Oncology

The blood-tumour barrier in cancer biology and therapy

Patricia S. Steeg

Summary: The blood-brain barrier plays a crucial role in maintaining normal brain function, but modifications in primary brain tumors and brain metastases result in the blood-tumor barrier, further limiting the penetration of therapeutic agents. This challenge highlights the importance of understanding and overcoming the structural and functional complexities of the blood-tumor barrier for improving cancer therapy and patient outcomes.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

添加到收藏夹

Review Plant Sciences

Honokiol: A review of its pharmacological potential and therapeutic insights

Abdur Rauf et al.

Summary: Honokiol, a pleiotropic compound isolated from Magnolia species, has shown a wide range of pharmacological potential and biological activities, making it a promising candidate for the treatment of various diseases. Its mechanisms of action include apoptosis, inhibition of oxidative stress, and suppression of pro-inflammatory cytokines, among others. Further studies are needed to establish its pharmacokinetics in humans.

PHYTOMEDICINE (2021)

添加到收藏夹

Review Oncology

Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions

Patrick Y. Wen et al.

NEURO-ONCOLOGY (2020)

添加到收藏夹

Article Oncology

Intravenous Honokiol in Drug-Resistant Cancer: Two Case Reports

Isaac Eliaz et al.

INTEGRATIVE CANCER THERAPIES (2020)

添加到收藏夹

Article Oncology

Honokiol Eliminates Glioma/Glioblastoma Stem Cell-Like Cells via JAK-STAT3 Signaling and Inhibits Tumor Progression by Targeting Epidermal Growth Factor Receptor

Yipu Fan et al.

CANCERS (2019)

添加到收藏夹

Article Plant Sciences

Safety and Toxicology of Magnolol and Honokiol

Andrea Sarrica et al.

PLANTA MEDICA (2018)

添加到收藏夹

Article Medicine, General & Internal

Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma A Randomized Clinical Trial

Roger Stupp et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)

添加到收藏夹

Article Pharmacology & Pharmacy

Honokiol Induces Apoptosis, G1 Arrest, and Autophagy in KRAS Mutant Lung Cancer Cells

Lian-Xiang Luo et al.

FRONTIERS IN PHARMACOLOGY (2017)

添加到收藏夹

Article Engineering, Biomedical

Liposomal honokiol induced lysosomal degradation of Hsp90 client proteins and protective autophagy in both gefitinib-sensitive and gefitinib-resistant NSCLC cells

Jianhong Yang et al.

BIOMATERIALS (2017)

添加到收藏夹

Article Oncology

Glioblastoma: Overview of Disease and Treatment

Mary Elizabeth Davis

CLINICAL JOURNAL OF ONCOLOGY NURSING (2016)

添加到收藏夹

Article Oncology

Bevacizumab for Recurrent Glioblastoma Multiforme: A Meta-Analysis

Eric T. Wong et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2011)

添加到收藏夹

Review Biochemistry & Molecular Biology

Honokiol, a Multifunctional Antiangiogenic and Antitumor Agent

Levi E. Fried et al.

ANTIOXIDANTS & REDOX SIGNALING (2009)

添加到收藏夹

Article Oncology

Liposomal honokiol, a promising agent for treatment of cisplatin-resistant human ovarian cancer

Hong Luo et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2008)

添加到收藏夹

Article Chemistry, Medicinal

Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models

Wenli Hou et al.

PHYTOTHERAPY RESEARCH (2008)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.